Similarly, Akt showed a significant upregulation after LVAD therapy (0.85 ± 0.30 vs. 0.38 ± 0.04, P = 0.047 by comparing CHF+LVAD vs. NF), which was otherwise irrespective of heart failure etiology. This evidence concerns the gene AKT1 and heart failure.